| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | triplex DNA binding | 6.83e-05 | 4 | 68 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 2.29e-04 | 35 | 68 | 3 | GO:0015020 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 1.81e-06 | 8 | 67 | 3 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 3.87e-06 | 10 | 67 | 3 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 7.06e-06 | 12 | 67 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 4.18e-05 | 21 | 67 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 8.07e-05 | 26 | 67 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 8.07e-05 | 26 | 67 | 3 | GO:0006063 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.38e-04 | 349 | 68 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 2.98e-04 | 40 | 68 | 3 | GO:0005640 | |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 4.61e-04 | 10 | 68 | 2 | GO:0031390 | |
| GeneOntologyCellularComponent | dynein complex | 7.25e-04 | 54 | 68 | 3 | GO:0030286 | |
| MousePheno | abnormal chromosome number | 2.34e-05 | 86 | 56 | 5 | MP:0004023 | |
| MousePheno | abnormal germ layer morphology | 4.29e-05 | 161 | 56 | 6 | MP:0014138 | |
| MousePheno | impaired somite development | 5.85e-05 | 104 | 56 | 5 | MP:0009768 | |
| MousePheno | abnormal embryonic tissue morphology | JAK3 TRIM45 TBX3 TRIT1 PTPN11 DDX12P TENM4 RASA1 DYNC2LI1 PCSK6 SOWAHB TXNDC12 DNAH11 DDX11 | 9.47e-05 | 1116 | 56 | 14 | MP:0002085 |
| MousePheno | abnormal chromosome morphology | 1.45e-04 | 126 | 56 | 5 | MP:0003702 | |
| MousePheno | abnormal mesoderm morphology | 1.51e-04 | 127 | 56 | 5 | MP:0014141 | |
| MousePheno | abnormal inferior vena cava morphology | 1.55e-04 | 68 | 56 | 4 | MP:0006063 | |
| MousePheno | abnormal heart looping | 2.01e-04 | 135 | 56 | 5 | MP:0000269 | |
| MousePheno | abnormal somite development | 2.51e-04 | 222 | 56 | 6 | MP:0001688 | |
| MousePheno | abnormal vena cava morphology | 2.52e-04 | 77 | 56 | 4 | MP:0006062 | |
| Domain | Rhs_assc_core | 3.68e-05 | 3 | 66 | 2 | IPR022385 | |
| Domain | UDPGT | 5.36e-05 | 21 | 66 | 3 | PF00201 | |
| Domain | UDPGT | 5.36e-05 | 21 | 66 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 5.36e-05 | 21 | 66 | 3 | IPR002213 | |
| Domain | Tox-GHH_dom | 7.35e-05 | 4 | 66 | 2 | IPR028916 | |
| Domain | Ten_N | 7.35e-05 | 4 | 66 | 2 | IPR009471 | |
| Domain | Ten_N | 7.35e-05 | 4 | 66 | 2 | PF06484 | |
| Domain | TENEURIN_N | 7.35e-05 | 4 | 66 | 2 | PS51361 | |
| Domain | Tox-GHH | 7.35e-05 | 4 | 66 | 2 | PF15636 | |
| Domain | YD | 1.22e-04 | 5 | 66 | 2 | IPR006530 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.74e-04 | 46 | 66 | 3 | IPR011042 | |
| Domain | NHL | 9.36e-04 | 13 | 66 | 2 | PS51125 | |
| Domain | PLAC | 1.09e-03 | 14 | 66 | 2 | PF08686 | |
| Domain | CarboxyPept-like_regulatory | 1.62e-03 | 17 | 66 | 2 | IPR008969 | |
| Domain | PLAC | 2.02e-03 | 19 | 66 | 2 | PS50900 | |
| Domain | PLAC | 2.02e-03 | 19 | 66 | 2 | IPR010909 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.68e-06 | 25 | 50 | 4 | M605 | |
| Pathway | REACTOME_PREDNISONE_ADME | 7.07e-05 | 23 | 50 | 3 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 8.06e-05 | 24 | 50 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 9.14e-05 | 25 | 50 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 9.14e-05 | 25 | 50 | 3 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 1.03e-04 | 26 | 50 | 3 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.29e-04 | 28 | 50 | 3 | M19580 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.51e-04 | 39 | 50 | 3 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 4.07e-04 | 41 | 50 | 3 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 5.02e-04 | 44 | 50 | 3 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 5.36e-04 | 45 | 50 | 3 | MM15694 | |
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 26074487 | ||
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 32093886 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 1.01e-06 | 536 | 68 | 9 | 15840001 | |
| Pubmed | 1.04e-06 | 538 | 68 | 9 | 10512203 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10222050 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17263731 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32855419 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 38185251 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 8833153 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15319348 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 9013641 | ||
| Pubmed | Vti1b promotes TRPV1 sensitization during inflammatory pain. | 5.20e-06 | 127 | 68 | 5 | 30335684 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 7835904 | ||
| Pubmed | Ski can negatively regulates macrophage differentiation through its interaction with PU.1. | 1.13e-05 | 3 | 68 | 2 | 17621263 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 8333863 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 29138287 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 17611414 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 11896619 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 21854770 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 22092298 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 2.25e-05 | 4 | 68 | 2 | 10225957 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 27869116 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 16849011 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 7642582 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 2.25e-05 | 4 | 68 | 2 | 12000766 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 23065156 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 15318931 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 8618896 | ||
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 4.42e-05 | 327 | 68 | 6 | 15592455 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 18245468 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 8890167 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 21030595 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 10625539 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 12915301 | ||
| Pubmed | Genome wide molecular analysis of minimally differentiated acute myeloid leukemia. | 7.86e-05 | 7 | 68 | 2 | 19773259 | |
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 22678773 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 18052087 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 10331952 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 9564850 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 10748067 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 18719240 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 20142249 | ||
| Pubmed | 1.05e-04 | 963 | 68 | 9 | 28671696 | ||
| Pubmed | A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation. | 1.34e-04 | 9 | 68 | 2 | 15574420 | |
| Pubmed | 1.39e-04 | 51 | 68 | 3 | 16919471 | ||
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 22284677 | ||
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 38713721 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.45e-04 | 12 | 68 | 2 | 20308471 | |
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 18161889 | ||
| Pubmed | 3.00e-04 | 66 | 68 | 3 | 19898482 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 3.44e-04 | 477 | 68 | 6 | 31300519 | |
| Pubmed | TENM4 GPR158 SQSTM1 SPHKAP EIF3B SLC4A4 SNAP47 TENM2 TXNDC12 | 3.65e-04 | 1139 | 68 | 9 | 36417873 | |
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 10790433 | ||
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 21572416 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 4.64e-04 | 328 | 68 | 5 | 23398456 | |
| Pubmed | ATF4 May Be Essential for Adaption of the Ocular Lens to Its Avascular Environment. | 5.03e-04 | 17 | 68 | 2 | 37998373 | |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 5.03e-04 | 17 | 68 | 2 | 19727691 | |
| Pubmed | 5.03e-04 | 17 | 68 | 2 | 21924257 | ||
| Pubmed | 5.65e-04 | 18 | 68 | 2 | 34407391 | ||
| Pubmed | 5.65e-04 | 18 | 68 | 2 | 20056724 | ||
| Pubmed | 6.74e-04 | 87 | 68 | 3 | 29991678 | ||
| Pubmed | Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. | 7.00e-04 | 20 | 68 | 2 | 17251353 | |
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 7.44e-04 | 90 | 68 | 3 | 16273093 | |
| Pubmed | Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. | 7.72e-04 | 21 | 68 | 2 | 22190037 | |
| Pubmed | Transcriptional Repression of Aerobic Glycolysis by OVOL2 in Breast Cancer. | 8.70e-04 | 95 | 68 | 3 | 35896951 | |
| Pubmed | 1.00e-03 | 225 | 68 | 4 | 12168954 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.01e-03 | 100 | 68 | 3 | 25807483 | |
| Pubmed | 1.01e-03 | 100 | 68 | 3 | 24859004 | ||
| Pubmed | 1.07e-03 | 102 | 68 | 3 | 11214970 | ||
| Pubmed | Chromatin regulation by Brg1 underlies heart muscle development and disease. | 1.10e-03 | 25 | 68 | 2 | 20596014 | |
| Pubmed | Murine craniofacial development requires Hdac3-mediated repression of Msx gene expression. | 1.19e-03 | 26 | 68 | 2 | 23506836 | |
| Pubmed | 1.19e-03 | 405 | 68 | 5 | 38187761 | ||
| Pubmed | 1.22e-03 | 407 | 68 | 5 | 12693553 | ||
| Pubmed | 1.33e-03 | 110 | 68 | 3 | 27889896 | ||
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 1.38e-03 | 28 | 68 | 2 | 20309963 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 1.62e-03 | 118 | 68 | 3 | 27377895 | |
| Pubmed | Nkx2-5 regulates cardiac growth through modulation of Wnt signaling by R-spondin3. | 1.69e-03 | 31 | 68 | 2 | 25053429 | |
| Pubmed | 1.80e-03 | 32 | 68 | 2 | 9611252 | ||
| Pubmed | 1.80e-03 | 32 | 68 | 2 | 22974441 | ||
| Pubmed | Analysis of mouse embryonic patterning and morphogenesis by forward genetics. | 1.91e-03 | 33 | 68 | 2 | 15755804 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 1.92e-03 | 125 | 68 | 3 | 36030824 | |
| Pubmed | 1.92e-03 | 125 | 68 | 3 | 29467281 | ||
| Interaction | DYNLT5 interactions | 4.34e-06 | 10 | 68 | 3 | int:DYNLT5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 9.04e-05 | 157 | 68 | 4 | chr4q13 | |
| Cytoband | 4q13 | 2.24e-04 | 15 | 68 | 2 | 4q13 | |
| Cytoband | 3p22.2 | 5.84e-04 | 24 | 68 | 2 | 3p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p22 | 2.62e-03 | 184 | 68 | 3 | chr3p22 | |
| GeneFamily | UDP glucuronosyltransferases | 8.25e-05 | 32 | 48 | 3 | 363 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 5.17e-06 | 169 | 68 | 6 | M39230 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-06 | 175 | 68 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-06 | 179 | 68 | 5 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 181 | 68 | 5 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.46e-06 | 181 | 68 | 5 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.46e-06 | 181 | 68 | 5 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.46e-06 | 181 | 68 | 5 | 166ff44fcc0a2943b7f485ea8a9c314964e013bb | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.46e-06 | 181 | 68 | 5 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|IPF / Disease state, Lineage and Cell class | 1.07e-05 | 190 | 68 | 5 | e539ebc0f4c5ee5dba86c614387be7d91338ad47 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 192 | 68 | 5 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | Lung_Parenchyma-Control|Lung_Parenchyma / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-05 | 200 | 68 | 5 | 2cb0fba2477d885b62850e473b4b637a5af531a9 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.37e-05 | 200 | 68 | 5 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-05 | 153 | 68 | 4 | d6526d17826470534b766df144c74e73eb83fdad | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-05 | 153 | 68 | 4 | 2731c3d4ac40ecc22108f8f3f45a069077159125 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 166 | 68 | 4 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 166 | 68 | 4 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 168 | 68 | 4 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 168 | 68 | 4 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-04 | 169 | 68 | 4 | 29db25e7c5f31d98a08a35d7ec5ade203242bc50 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 169 | 68 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-04 | 169 | 68 | 4 | b1611e61f635f8f9b87250e026ad30999cbee041 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 170 | 68 | 4 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 170 | 68 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.39e-04 | 172 | 68 | 4 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 173 | 68 | 4 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 176 | 68 | 4 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promyelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.52e-04 | 176 | 68 | 4 | ee33d7077a92c1fd371081e7c990c7266e711957 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 177 | 68 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 178 | 68 | 4 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 179 | 68 | 4 | ce95b601bf17ae8167d382a105384b9e65e9407f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-04 | 181 | 68 | 4 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 181 | 68 | 4 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 182 | 68 | 4 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 182 | 68 | 4 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.72e-04 | 182 | 68 | 4 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-04 | 182 | 68 | 4 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 183 | 68 | 4 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 184 | 68 | 4 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 184 | 68 | 4 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgM_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.83e-04 | 185 | 68 | 4 | 26ea60b6392410fab048f2e406a9860a018429cc | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 1.83e-04 | 185 | 68 | 4 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.83e-04 | 185 | 68 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 185 | 68 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-04 | 186 | 68 | 4 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 186 | 68 | 4 | 4bb54043f944a979db91bde9a86dd66f498c7658 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.87e-04 | 186 | 68 | 4 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.91e-04 | 187 | 68 | 4 | fa8f221b4c2df61eadaa9c77e4cf45848b00330b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 187 | 68 | 4 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 1.95e-04 | 188 | 68 | 4 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 188 | 68 | 4 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.95e-04 | 188 | 68 | 4 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-04 | 189 | 68 | 4 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 2.03e-04 | 190 | 68 | 4 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.03e-04 | 190 | 68 | 4 | 2592765016f291565697265800a232b2edef3792 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 190 | 68 | 4 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 190 | 68 | 4 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 191 | 68 | 4 | eec14997d2bfc7e6b5a601afc43a147f6b96d668 | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 191 | 68 | 4 | 1730ec5dc1cfd2f0cba7e21555641c7bce97e09d | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 2.07e-04 | 191 | 68 | 4 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 191 | 68 | 4 | 4b77abc68bd72c64e7062f9527fe9d9605289ceb | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.07e-04 | 191 | 68 | 4 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.11e-04 | 192 | 68 | 4 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-04 | 192 | 68 | 4 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 2.16e-04 | 193 | 68 | 4 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 193 | 68 | 4 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 193 | 68 | 4 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 193 | 68 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.20e-04 | 194 | 68 | 4 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | Mesenchymal_cells-Endosteal_fibro.|Mesenchymal_cells / Lineage and Cell class | 2.20e-04 | 194 | 68 | 4 | 9a4b5de4d1d8a0aa76fed7b36548ea628f3009cc | |
| ToppCell | normal_Lung|World / Location, Cell class and cell subclass | 2.20e-04 | 194 | 68 | 4 | affae83d7f982d18117f5b95705f09809f304b0b | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|CTRL / Disease state, Lineage and Cell class | 2.20e-04 | 194 | 68 | 4 | be69b20afa915978c4cf2feb0bb21ab7c1f301a5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 194 | 68 | 4 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 194 | 68 | 4 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 195 | 68 | 4 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 195 | 68 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.24e-04 | 195 | 68 | 4 | 2fa0216ba493d9722324c0a9a0c59c40e72b3c4e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells-retina_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.24e-04 | 195 | 68 | 4 | 06a437459717dc3c41ec343b1ec57cf910ecbdd8 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.24e-04 | 195 | 68 | 4 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.24e-04 | 195 | 68 | 4 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | tumor_Lung-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.24e-04 | 195 | 68 | 4 | 3133591a289c06396cf4705d6a861369e145ac54 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.29e-04 | 196 | 68 | 4 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Control|World / Condition, Lineage and Cell class | 2.29e-04 | 196 | 68 | 4 | 2565f567c5274d1689e11600a2cb9e6770b65f74 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.29e-04 | 196 | 68 | 4 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.29e-04 | 196 | 68 | 4 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.29e-04 | 196 | 68 | 4 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-04 | 197 | 68 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-AM-AM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.33e-04 | 197 | 68 | 4 | 360f75ba6845128b045959e133e38ffd3d377ed9 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.33e-04 | 197 | 68 | 4 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.33e-04 | 197 | 68 | 4 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | nucseq-Immune-Immune_Myeloid-AM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.33e-04 | 197 | 68 | 4 | edb652af64d296b9031c9a690f0c70895a5eda2c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 197 | 68 | 4 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.33e-04 | 197 | 68 | 4 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.38e-04 | 198 | 68 | 4 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-04 | 198 | 68 | 4 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-04 | 198 | 68 | 4 | 1774dd36315a04c4cdcef2cc674204e4ab9c175b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-04 | 198 | 68 | 4 | 768df928a3265dbe7cce2acea07b2f6d6b709642 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 199 | 68 | 4 | 1bb02f41f3cc76a28581e38b0ca4c36b930b85b4 | |
| ToppCell | Control-Myeloid-TRAM1|Control / Condition, Lineage and Cell class | 2.42e-04 | 199 | 68 | 4 | 8785ea74b006df8d115885eaad429289c41e8d5b | |
| Drug | 7,8-benzoquinoline | 8.22e-06 | 43 | 68 | 4 | CID000009191 | |
| Drug | 2-hydroxyestriol | 8.79e-06 | 2 | 68 | 2 | ctd:C008012 | |
| Drug | C1 11-32 | 2.01e-05 | 18 | 68 | 3 | CID000443077 | |
| Drug | C11131 | 2.01e-05 | 18 | 68 | 3 | CID000443076 | |
| Drug | T4-G | 2.39e-05 | 19 | 68 | 3 | CID000152424 | |
| Drug | 5 alpha-dihydroaldosterone | 2.63e-05 | 3 | 68 | 2 | CID003036614 | |
| Drug | NSC76436 | 2.80e-05 | 20 | 68 | 3 | CID000002828 | |
| Drug | MK-886; Up 200; 1uM; MCF7; HG-U133A | 2.80e-05 | 198 | 68 | 6 | 264_UP | |
| Drug | UDP-alpha-d-xylopyranose | 3.13e-05 | 60 | 68 | 4 | CID000001165 | |
| Drug | estriol-16-glucuronide | 3.26e-05 | 21 | 68 | 3 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 4.32e-05 | 23 | 68 | 3 | CID000066651 | |
| Drug | Hymecromone | 5.59e-05 | 25 | 68 | 3 | ctd:D006923 | |
| Drug | L-idaro-1,4-lactone | 7.91e-05 | 28 | 68 | 3 | CID000078997 | |
| Drug | hyodeoxycholic acid | 8.74e-05 | 5 | 68 | 2 | ctd:C010471 | |
| Drug | Amobarbital | 8.74e-05 | 5 | 68 | 2 | ctd:D000654 | |
| Drug | phenolphthalin | 8.74e-05 | 5 | 68 | 2 | CID000066494 | |
| Drug | AC1N8H7N | 8.79e-05 | 78 | 68 | 4 | CID004318740 | |
| Drug | 7-hydroxycoumarin glucuronide | 8.81e-05 | 29 | 68 | 3 | CID000125641 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 9.74e-07 | 9 | 68 | 3 | EFO_0600040 | |
| Disease | X-19141 measurement | 3.29e-06 | 13 | 68 | 3 | EFO_0800799 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 1.57e-05 | 3 | 68 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | X-24947 measurement | 1.75e-05 | 22 | 68 | 3 | EFO_0800910 | |
| Disease | Cluster headache | 5.21e-05 | 5 | 68 | 2 | HP_0012199 | |
| Disease | vitamin D deficiency | 8.60e-05 | 37 | 68 | 3 | EFO_0003762 | |
| Disease | juvenile myelomonocytic leukemia (is_implicated_in) | 1.09e-04 | 7 | 68 | 2 | DOID:0050458 (is_implicated_in) | |
| Disease | vitamin D measurement | 1.26e-04 | 336 | 68 | 6 | EFO_0004631 | |
| Disease | fibromuscular dysplasia | 1.45e-04 | 44 | 68 | 3 | EFO_1000938 | |
| Disease | vitamin D measurement, COVID-19 | 2.00e-04 | 49 | 68 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | response to vaccine, cytokine measurement | 2.42e-04 | 131 | 68 | 4 | EFO_0004645, EFO_0004873 | |
| Disease | bipolar I disorder | 3.21e-04 | 141 | 68 | 4 | EFO_0009963 | |
| Disease | disease progression measurement | 3.83e-04 | 61 | 68 | 3 | EFO_0008336 | |
| Disease | unipolar depression, bipolar disorder | 4.71e-04 | 156 | 68 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | late-onset Alzheimers disease | 5.75e-04 | 292 | 68 | 5 | EFO_1001870 | |
| Disease | myopia (is_implicated_in) | 6.15e-04 | 16 | 68 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement | 6.96e-04 | 17 | 68 | 2 | EFO_0010543, EFO_0010544 | |
| Disease | bacteriemia | 6.96e-04 | 17 | 68 | 2 | EFO_0003033 | |
| Disease | phosphatidylcholine 36:4 measurement | 7.82e-04 | 18 | 68 | 2 | EFO_0010382 | |
| Disease | serum alanine aminotransferase measurement | 8.51e-04 | 869 | 68 | 8 | EFO_0004735 | |
| Disease | emphysema pattern measurement | 8.72e-04 | 19 | 68 | 2 | EFO_0005850 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 8.72e-04 | 19 | 68 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 8.72e-04 | 19 | 68 | 2 | C0587248 | |
| Disease | Juvenile Myelomonocytic Leukemia | 8.72e-04 | 19 | 68 | 2 | C0349639 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 8.72e-04 | 19 | 68 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 8.72e-04 | 19 | 68 | 2 | C1275081 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.08e-03 | 195 | 68 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | LEOPARD Syndrome | 1.17e-03 | 22 | 68 | 2 | C0175704 | |
| Disease | neuritic plaque measurement | 1.27e-03 | 349 | 68 | 5 | EFO_0006798 | |
| Disease | Noonan Syndrome | 1.40e-03 | 24 | 68 | 2 | C0028326 | |
| Disease | glaucoma (biomarker_via_orthology) | 1.90e-03 | 28 | 68 | 2 | DOID:1686 (biomarker_via_orthology) | |
| Disease | Mental deterioration | 2.04e-03 | 29 | 68 | 2 | HP_0001268 | |
| Disease | diverticular disease | 2.18e-03 | 236 | 68 | 4 | EFO_0009959 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRFKAEKVEFHWGHS | 141 | P23470 | |
| HADFGGHGTIWKLFL | 196 | O00590 | |
| EKEAKAHHIGWQRIG | 246 | Q8NEM8 | |
| IWDILTGHKKRGFHC | 406 | P55884 | |
| DKLHRTALHWACLKG | 141 | Q86SG2 | |
| KEFDWLISDRGPFHH | 36 | O60477 | |
| NHEFWRKEIHGRIKD | 26 | Q8N7M0 | |
| FIHHATREWKDGKIV | 2216 | Q96DT5 | |
| GEELDKLWREFLHHK | 166 | P30533 | |
| KKERQPLHWAAFLGH | 171 | Q8NB46 | |
| LKRGLENTLHDAKHW | 341 | Q13515 | |
| WQSALIGKNGKRHDH | 371 | Q8TE60 | |
| REEDPHEGKIWFHGK | 341 | P20936 | |
| GSRFHAILWHKHLDD | 526 | Q5JS13 | |
| LEWHENLGHGSFTKI | 521 | P52333 | |
| GEWKAGRKHGHGKLL | 41 | Q5T089 | |
| GDREWAAHIKSKSHL | 406 | Q9H3H1 | |
| FGHRPHKDLWASKNE | 456 | Q9UHB6 | |
| WKDGKELLGAHHAIT | 131 | Q12866 | |
| RRKDGLGGDKSHFKW | 251 | Q5T848 | |
| ARAEPGKFWHIADLH | 16 | Q92485 | |
| KEGWKHRLFLSHREG | 61 | Q9UPZ3 | |
| KHGGWLLREHQAGFE | 271 | Q9C098 | |
| RAKGHNTPKDIAHFW | 71 | Q8TCX1 | |
| AHLKASDWKVNGAGH | 456 | P29122 | |
| QRIHDGKEKPGALWH | 1601 | Q7LBC6 | |
| RWFHGHLSGKEAEKL | 111 | Q06124 | |
| VHAHWEKGGLLGRLA | 716 | Q96FC9 | |
| AINWAGGLHHAKKFE | 126 | O15379 | |
| WHHSDLLRKGGEESL | 791 | Q9Y2F5 | |
| HDAWLSKHFGIDRKS | 1336 | Q5JSL3 | |
| VLGIHAKGERLKHWF | 371 | Q14184 | |
| KDLLDRGHFLSGWHT | 106 | Q15485 | |
| VAHKKSEWEGRTHAL | 36 | Q96MT8 | |
| HAHWEKGGLLGRLAA | 736 | Q92771 | |
| EWKGGLLEHKMGHLT | 461 | P33908 | |
| HHGLSEGWKETEKFG | 211 | Q6UWP8 | |
| DRSGKAVHRLFGKWH | 741 | Q9H4L5 | |
| IRKAHPDKDWFHLVG | 106 | Q9UGB7 | |
| HLKRFGLWKSKDDNH | 566 | Q9BQF6 | |
| VHRKSWKVGDIFHAV | 1661 | Q2M3C7 | |
| IHKHGDSVWELLKGT | 231 | Q9H8W5 | |
| HLEAKELWDQFHKRG | 106 | O15119 | |
| LEKGHAKHWFSSLRP | 116 | Q5SQN1 | |
| HTHAAKDFWKLLGGQ | 1526 | O95425 | |
| AHETGLPWAGLHKRK | 656 | Q8IUH8 | |
| LGGWSLDKHHILNVK | 1176 | Q9NT68 | |
| KGDKLLRHWASEIEH | 401 | Q8TC41 | |
| FSSKHKEALAHRWGI | 201 | P17947 | |
| GYTALHWIAKHGDLR | 631 | A6NEL2 | |
| SEGFSHSRWLRKVKH | 176 | Q13501 | |
| GDSWKELAHRAFFHG | 286 | P54922 | |
| KGAKHLRVAAHDLTW | 471 | P06133 | |
| WKLNFQHLSGERGHK | 26 | C9JQI7 | |
| AVSARFGHWHKNKAG | 511 | Q15833 | |
| FGHWHKNKAGIEARA | 516 | Q15833 | |
| LVWHRRLHGGEKSYK | 666 | Q8N4W9 | |
| SKLGGWSLDKHHALN | 1166 | Q6N022 | |
| KGAKHLRVAAHDLTW | 471 | O75310 | |
| AGLFLWLIGRHDKAK | 116 | Q8NDW8 | |
| LHHKGFKLWFDELIG | 226 | Q14997 | |
| AFDWKSQLVIHRKGH | 431 | Q9NWS9 | |
| HVRGHLKRLGKTKWD | 1056 | Q9H582 | |
| HKLKKGAGYHLDLFW | 811 | Q9Y6R1 | |
| VFRGHKKEATAVAWH | 326 | Q9C0J8 | |
| KGAKHLRVAAHDLTW | 471 | P16662 | |
| TWKHLHADRIGRGSK | 446 | Q8NA31 | |
| GKGFGDHIHWRTLED | 31 | O95881 | |
| ESLHEWKECGRGFIH | 181 | Q14584 |